July Monthly Lecture: Practical considerations associated with biosimilar medicines

Use this page to register for Parkville or Victorian satellite sites.

To register to watch this remotely (online) go to www.psa.org.au/branch-events/national-webinars

The introduction of biosimilar medicines has widened the scope of brand substitution in Australia. With nine brands of biosimilar medicines currently approved for use in Australia, seven of which are also listed on the PBS, pharmacists will be increasingly faced with opportunities to engage consumers in discussions about biosimilar substitution.

Biosimilar medicines encourage competition in the Australian market, leading to a reduction in the cost of medicines. Lower prices improve affordability of, and access to new treatments for seriously ill patients, and create savings for the healthcare system. It is essential that pharmacists are able to educated consumers about biosimilar medicines to facilitate safe and appropriate substitution.

Join Professor Geoff McColl, Associate Professor Michael Ward and Franca Marine for an interactive Q&A session* exploring practical considerations associated with biosimilar substitution, including the application of the revised Professional Practice Standards.

Participants are encouraged to complete the background module: Biosimilars for Pharmacists prior to the webinar. After enrolling in the webinar you will receive an alert when module is released.

*Participants participating remotely are able to ask questions via twitter handle @psa_national #biosimilarsq&a

At the end of this session, you will be able to:

1. Explain differences between generic medicines and biosimilar medicines.

2. Discuss practical considerations when substituting biological medicines.

3. Counsel patients on biosimilar medicines to facilitate safe and appropriate substitution.

Competency Standards: 1.1.3, 3.1.2, 3.2.3, 3.2.5

Correct at the time of publication and subject to change

**Networking and refreshments from 7pm**

PSA gratefully acknowledges the Australian Government Department of Health for providing funding for this webinar as part of the PBS Access and Sustainability Package including the Sixth Community Pharmacy Agreement.